Skip to main content
. 2016 Aug 11;9:68. doi: 10.1186/s13045-016-0297-7

Table 2.

Study subject treatment cycles completed

Combination therapy study: utidelone (30 mg/m2/day) + capecitabine (2000 mg/m2/day) n = 33 Monotherapy study: utidelone (40 mg/m2/day) n = 70
Utidelone dose 30 mg/m2/day for 5 days per cycle 40 mg/m2/day for 5 days per cycle
Cycles completed
 1 1 7
 2 5 24
 3 2 4
 4 4 10
 5 3 5
 ≥6a 18 20
 Median 6 3.5
 Mean 4.82 3.64

aCompassionate treatment for additional treatment beyond 6 cycles were allowed for some patients for their benefits